FDA Approves Botox for Chronic Migraine Treatment
(About.com) After a decade of study and debate, the Food and Drug Administration has finally approved Botox to treat chronic migraines. Patients who experience debilitating migraines 14 days a month or more may experience a reduction in their symptoms with
Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 829 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 829]
updated 829 (Headaches and Migraine), inserted 2, updated 0, at 2012-05-31 05:35:49